- Companies
- Preventice Solutions
Preventice Solutions Acquisition, Valuation, Funding & Investors
Preventice Solutions was acquired by Boston Scientific for $1.2B in January 2021, a 7.6x multiple on $158M of revenue.
Preventice Solutions revenue at acquisition
$158M
Last twelve months · Jan 2021
Preventice Solutions revenue multiple at acquisition
7.6x
EV/Revenue · Jan 2021
Cumulative funding Preventice Solutions raised
$137M
across 1 funding round
About Preventice Solutions
Preventice Solutions is a Mayo Clinic spinout based in Rochester, Minnesota, specializing in remote cardiac diagnostics. Acquired by Boston Scientific in 2017, it provides Zio platform for ambulatory ECG monitoring worn up to 14 days. The service processes over one million recordings annually for U.S. providers. Preventice Solutions links wearables to hospital workflows for arrhythmia management.
Founded
2007
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Services
Revenue
$158M (Jan 2021)
Valuation
$1.2B (acquired Jan 2021)
Preventice Solutions Acquisition
Preventice Solutions was acquired by Boston Scientific for $1.2B on 21 January 2021.
The acquisition price implies a 7.6x revenue multiple on $158M of revenue.
Before the acquisition Preventice Solutions had raised $137M across 1 funding round.
| Acquirer | Date | Type | Price | EV/Revenue |
|---|---|---|---|---|
| 21 Jan 2021 | Strategic M&A | $1.2B | 7.6x |
Preventice Solutions Funding History
Preventice Solutions has raised a total of $137M across 1 funding round.
Preventice Solutions funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jul 2020 | Series B | Vivo Capital (lead); Novo Holdings; Samsung Catalyst Fund; Merck Global Health Innovation Fund; Boston Scientific | $137M | Preventice Solutions, a Houston-based digital health company founded in 2004, develops reusable wearable patches for remote cardiac arrhythmia monitoring paired with a smartphone app and cloud-based platform. The company raised $137 million in a Series B round on July 15, 2020, led by Vivo Capital with participation from new investor Novo Holdings and existing investors Boston Scientific, Merck Global Health Innovation Fund, and Samsung Catalyst Fund. Funds were allocated to expand the sales team, advance technology and product innovation, and develop clinical evidence for its flagship solution. Preventice positions itself as a leader in the growing remote patient monitoring space, leveraging software expertise for scalable mobile and cloud solutions to improve arrhythmia diagnosis and healthcare efficiency. CEO Jon P. Otterstatter highlighted robust success with physicians and payers. The round brought total equity funding to $137 million across rounds. Digital health wearable sensor companies raised $312 million in H1 2020 per Mercom report. Post-round, Joe Siletto from Vivo Capital joined the board. |
Who has invested in Preventice Solutions?
5 investors have backed Preventice Solutions across its funding rounds, including Novo Holdings, Vivo Capital, Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund.
Lead investors include Vivo Capital.
Preventice Solutions Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | Jul 2020 | ||
| 1 | Participant | Jul 2020 | ||
| 1 | Lead | Jul 2020 | ||
This data is available for Pro users. Sign up to see all 5 Preventice Solutions investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialPreventice Solutions Competitors
Preventice Solutions competitors include listed companies like GoodRx and Teladoc, and private ones like Assort Health, Tala Health, Wheel and League.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $3M | - | $1.2B | - | ||
| Private | - | - | $1.2B | - | ||
| Private | - | - | $1.2B | - | ||
| Private | - | - | $1.2B | - | ||
| Publicly listed | $797M | $173M | $1.2B | 1.8x | ||
| Publicly listed | $2.5B | $124M | $1.1B | 0.6x |
Preventice Solutions Public Comps
Preventice Solutions is no longer listed, but its public comps include GoodRx, Teladoc, JMDC, Talkspace, Ping An Healthcare, Guiyang Longmaster, Medley Inc., American Well, Nyxoah and LifeMD.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $797M | $173M | 1.8x | 1.8x | 8.1x | 5.5x | |||
| $2.5B | $124M | 0.6x | 0.6x | 11.3x | 5.0x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $229M | $6M | 3.4x | 3.4x | 129.3x | 49.4x | |||
| $815M | $52M | 0.9x | 0.9x | 13.4x | 16.9x | |||
| $44M | $5M | 10.0x | - | 87.9x | - | |||
| $236M | $32M | 2.1x | 1.8x | 15.7x | 13.2x | |||
| $249M | ($63M) | 0.2x | 0.2x | (0.8x) | (3.1x) | |||
This data is available for Pro users. Sign up to see all Preventice Solutions competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Preventice Solutions
| When was Preventice Solutions founded? | Preventice Solutions was founded in 2007. |
| Where is Preventice Solutions headquartered? | Preventice Solutions is headquartered in Houston, TX, United States. |
| Is Preventice Solutions publicly listed? | No, Preventice Solutions was acquired by Boston Scientific in January 2021. |
| Who acquired Preventice Solutions? | Preventice Solutions was acquired by Boston Scientific in January 2021. |
| How much was Preventice Solutions acquired for? | Preventice Solutions was acquired for $1.2B in January 2021, a 7.6x revenue multiple. |
| How much funding has Preventice Solutions raised? | Preventice Solutions has raised $137M across 1 funding round. |
| What was Preventice Solutions' last funding round? | Preventice Solutions' last funding round was a $137M Series B in July 2020, led by Vivo Capital. |
| Who are Preventice Solutions' investors? | Preventice Solutions' investors include Novo Holdings, Samsung Catalyst Fund, Vivo Capital, Merck Global Health Innovation Fund and Boston Scientific. |
| Which companies are comparable to Preventice Solutions? | Companies comparable to Preventice Solutions include Assort Health, Tala Health, Wheel, League, GoodRx and Teladoc. |
See companies similar to Preventice Solutions
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




